Monitoring MLTX open interest helps you see where real money is positioned on MoonLake Immunotherapeutics's options and which strikes are attracting the most commitment from traders. MoonLake Immunotherapeutics's open interest reflects the total number of outstanding contracts that have not been closed or exercised, making it a powerful gauge of liquidity, conviction, and potential support and resistance zones. Use our scanner to monitor MLTX options open interest in real time and find the strikes that matter.
Open interest is distinct from volume: volume counts how many contracts are traded in a session, while open interest counts how many remain open at the end of the day. Rising MLTX options open interest alongside rising volume suggests new positions are being built, while falling open interest signals positions are being closed. Heavy open interest at specific strikes often acts as a magnet near expiration and can hint at where dealers and large traders expect MoonLake Immunotherapeutics to settle.
MoonLake Immunotherapeutics, a clinical-stage biopharmaceutical company, engages in developing therapies. It is developing Sonelokimab, a novel investigational Nanobody therapy for the treatment of inflammation. The company is involved in conducting Phase II trials for hidradenitis suppurativa, psoriatic arthritis, ankylosing spondylitis, or radiographic axial spondyloarthritis. MoonLake Immunotherapeutics was founded in 2021 and is headquartered in Zug, Switzerland.
Pin risk into expiration, dealer positioning, liquidity checks for large orders — all of it starts with knowing where MLTX open interest is concentrated. Our scanner maps MoonLake Immunotherapeutics's open interest across every strike and expiry, flags unusual buildups, and lets you drill into the contracts that institutional money is actually holding. Trade MoonLake Immunotherapeutics's options open interest as the signal it is, not as an afterthought.
